0 Kommentare
0 Anteile
117 Ansichten
0 Vorschau
Search
Entdecken Sie neue Leute, neue Verbindungen zu schaffen und neue Freundschaften
-
NEUIGKEITEN
- EXPLORE
-
Seiten
-
Gruppen
-
Veranstaltungen
- Blogs
- Angebote
- Jobs
- Please log in to like, share and comment!
- Are Surgical Innovations Improving Outcomes in Lung Cancer Treatment?Lung Cancer Surgery Market Summary: According to the latest report published by Data Bridge Market Research, the Lung Cancer Surgery Market CAGR Value This global Lung Cancer Surgery Market report is a wonderful guide to achieve an information or key data about market, emerging trends, product usage, motivating factors for customers, competitor strategies, brand...0 Kommentare 0 Anteile 90 Ansichten 0 Vorschau
- Brigatinib API Market to Reach 89.7 Million by 2034 Driven by Rising Lung Cancer CasesAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Kommentare 0 Anteile 81 Ansichten 0 Vorschau
- Global MET Inhibitors for Lung Cancer Market to Reach USD 2.5 Billion by 2032 at 8.5% CAGRAccording to a newly published market research report by 24LifeSciences, the global MET inhibitors for lung cancer market was valued at USD 1.1 billion in 2024 and is projected to reach USD 2.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252032. MET inhibitors represent a breakthrough class of targeted cancer therapies...0 Kommentare 0 Anteile 273 Ansichten 0 Vorschau
- Lung Cancer Surgery Market Growth, Global Opportunities, Analysis & Forecast Analysis By FMINEWARK, DE | The lung cancer surgery market stands at USD 1.6 billion in 2026 and is forecast to reach USD 2.8 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.9%. This sustained expansion reflects the critical role of surgical intervention in oncology, particularly for resectable early-stage non-small cell lung cancer (NSCLC), where...0 Kommentare 0 Anteile 312 Ansichten 0 Vorschau
© 2026 La Lingua Nostra
Deutsch